Skip to main content
. 2018 May 19;3:29. doi: 10.21037/tgh.2018.05.02

Table 2. Trials reporting number of patients with adequate versus poor visibility.

Studies Sim ± NAC group No Sim ± NAC group
Total patients Patients achieving adequate visibility Total patients Patients achieving adequate visibility
Ahsan et al. (32) 90 27/90 83 48/83
Elvas et al. (33) 199 1/199 (100%) 98 4/98 (96%)
Monrroy et al. (34) 138 57/138 46 26/46

Sim, Simethicone; NAC, N-acetyl cysteine.